Zentalis Pharmaceuticals Llc Stock Price on August 20, 2024
| ZNTL Stock | USD 3.50 0.11 3.05% |
Below is the normalized historical share price chart for Zentalis Pharmaceuticals Llc extending back to April 03, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Zentalis Pharmaceuticals stands at 3.50, as last reported on the 11th of December 2024, with the highest price reaching 3.72 and the lowest price hitting 3.45 during the day.
If you're considering investing in Zentalis Stock, it is important to understand the factors that can impact its price. Zentalis Pharmaceuticals appears to be somewhat reliable, given 3 months investment horizon. Zentalis Pharmaceuticals shows Sharpe Ratio of 0.0574, which attests that the company had a 0.0574% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Zentalis Pharmaceuticals, which you can use to evaluate the volatility of the company. Please utilize Zentalis Pharmaceuticals' Mean Deviation of 4.26, market risk adjusted performance of 0.2136, and Downside Deviation of 5.35 to validate if our risk estimates are consistent with your expectations.
The value of Total Stockholder Equity is estimated to slide to about 306.3 M. The value of Common Stock Total Equity is estimated to slide to about 50.4 K. The value of Price To Sales Ratio is estimated to slide to about 23.9 K. The value of Price Earnings Ratio is estimated to slide to -3.56. Zentalis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of April 2020 | 200 Day MA 7.2834 | 50 Day MA 3.3254 | Beta 1.742 |
Zentalis |
Sharpe Ratio = 0.0574
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ZNTL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.96 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Zentalis Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zentalis Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.7039 | Enterprise Value Ebitda (2.31) | Price Sales 6.8349 | Shares Float 51.1 M | Wall Street Target Price 9.5 |
Zentalis Pharmaceuticals Main Headline on 20th of August 2024
Analysts Set Zentalis Pharmaceuticals, Inc. Price Target at ... by news.google.com
Analysts Set Zentalis Pharmaceuticals, Inc. Price Target at 11.33 MarketBeat
Zentalis Pharmaceuticals Valuation on August 20, 2024
It is possible to determine the worth of Zentalis Pharmaceuticals on a given historical date. On August 20, 2024 Zentalis was worth 3.37 at the beginning of the trading date compared to the closed value of 3.14. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Zentalis Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Zentalis Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zentalis Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Zentalis Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 3.08 | 3.37 | 3.04 | 3.36 | 1,154,400 | |
08/20/2024 | 3.37 | 3.46 | 3.01 | 3.14 | 594,079 |
| 3.16 | 3.40 | 3.16 | 3.30 | 686,351 |
| Backtest Zentalis Pharmaceuticals | | | Zentalis Pharmaceuticals History | | | Zentalis Pharmaceuticals Valuation | Previous | Next |
Zentalis Pharmaceuticals Trading Date Momentum on August 20, 2024
| On August 21 2024 Zentalis Pharmaceuticals Llc was traded for 3.30 at the closing time. The top price for the day was 3.40 and the lowest listed price was 3.16 . The trading volume for the day was 686.4 K. The trading history from August 21, 2024 was a factor to the next trading day price upswing. The trading date delta against the next closing price was 5.10% . The trading date delta against the current closing price is 4.46% . |
Zentalis Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Zentalis Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Zentalis Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Zentalis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Zentalis Pharmaceuticals Stock history
Zentalis Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zentalis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zentalis Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zentalis Pharmaceuticals stock prices may prove useful in developing a viable investing in Zentalis Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 65.4 M | 46.9 M | |
| Net Loss | -213.1 M | -202.5 M |
Zentalis Pharmaceuticals Quarterly Net Working Capital |
|
Zentalis Pharmaceuticals Stock Technical Analysis
Zentalis Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Zentalis Pharmaceuticals Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Zentalis Pharmaceuticals Llc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Zentalis Pharmaceuticals December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Zentalis Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zentalis Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Zentalis Pharmaceuticals stock market strength indicators, traders can identify Zentalis Pharmaceuticals Llc entry and exit signals to maximize returns
Zentalis Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Zentalis Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Zentalis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zentalis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0617 | |||
| Jensen Alpha | 0.1865 | |||
| Total Risk Alpha | (0.52) | |||
| Sortino Ratio | 0.0582 | |||
| Treynor Ratio | 0.2036 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis Pharmaceuticals Llc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis Pharmaceuticals. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.50) | Revenue Per Share 0.572 | Return On Assets (0.25) | Return On Equity (0.43) |
The market value of Zentalis Pharmaceuticals is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zentalis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zentalis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.